Participation in clinical trials
Clinical trials test whether new approaches to treating diseases are safe, tolerable and effective. This allows new therapies and drugs to be developed. The aim is to improve patient care in the long term. Patients participating in a study receive treatment according to the latest scientific standards and gain early access to innovative treatment methods. Study participants undergo additional examinations beyond routine, are carefully monitored, and receive continued care even after the study concludes, with no costs incurred for them. As a patient, you are free to decide whether or not you wish to take part in a study. You can withdraw from participating in the study at any time without providing reasons, and this withdrawal will not result in any treatment disadvantages thereafter.
Learn more about clinical studies
Find trial in study finder
Are you looking for clinical trials for children or adults with cancer? With the help of our “Study Finder” you can find all oncology studies of the university hospitals of Zurich and direct contact persons who will be happy to help you.
Clinical trial program at the CCCZ
The CCCZ coordinates a comprehensive program for clinical studies in oncology. The CCCZ Clinical Trial Program forms the cornerstone of a comprehensive strategy aimed at providing access to clinical trials and innovative treatment methods to as many patients as possible. As part of the program, the translational, patient-centric research and the development of clinical trials at CCCZ are also intended to be promoted. Further measures include the standardization of administrative and operational processes, the establishment of digital platforms for study management, and the establishment of a CCCZ Study Center. Work is also underway to develop a Zurich study network aimed at expanding the range and scope of clinical studies in collaboration with surrounding hospitals. The CCCZ already works closely with the Swiss Group for Clinical Cancer Research (SAKK).
